Single-photon Emission Computed Tomography (SPECT) to Predict Peritoneal Chemotherapy

Single-photon Emission Computed Tomography for Prediction of Treatment Results in Sequential Intraperitoneal Chemotherapy at Peritoneal Carcinomatosis

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00997633

Enrollment

Registered

2009-10-19

Start date

1991-05-31

Completion date

2004-08-31

Last updated

2009-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peritoneal Carcinomatosis

Keywords

Intraperitoneal volume, peritoneal carcinomatosis, cytoreductive surgery, SPECT, intraperitoneal chemotherapy

Brief summary

SPECT was performed in 51 patients after cytoreductive surgery in combination with intraperitoneal chemotherapy. The detected volume was compared to the number of subsequent sequential postoperative intraperitoneal chemotherapy courses that could be performed without further surgical intervention. SPECT data was found to predict feasibility of sequential postoperative intraperitoneal chemotherapy.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Eligibility

Sex/Gender

ALL

Age

14 Years to 74 Years

Healthy volunteers

Inclusion criteria

* Cytoreductive surgery and intraperitoneal chemotherapy * Single-Photon Emission Computed Tomography (SPECT) before the second course of treatment

Design outcomes

Primary

Measure	Time frame
Detected volume measured by SPECT compared to the number of subsequent sequential postoperative intraperitoneal chemotherapy courses	—

Secondary

Measure	Time frame
The relationship between SPECT, feasibility of SPIC (intraperitoneal chemotherapy), and clinical variables	—

Countries

Sweden

Outcome results